The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111): a systematic review and economic model

Mary Bond , Gabriel Rogers, Jaime Peters, Rob Anderson, Martin Hoyle, Alec Miners, Tiffany Moxham, Sarah Davis, Praveen Thokala, Allan Wailoo, Mike Jeffreys, Chris Hyde

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyNational Institute for Health and Care Excellence (NICE)
Number of pages403
Publication statusPublished - 2010
Externally publishedYes

Cite this